298 related articles for article (PubMed ID: 26417884)
21. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.
Jiang YH; Jhang JF; Chen SF; Kuo HC
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535789
[TBL] [Abstract][Full Text] [Related]
22. What is the true catheterization rate after intravesical onabotulinumtoxinA injection?
Patel DN; Jamnagerwalla J; Houman J; Anger JT; Eilber KS
Int Urogynecol J; 2018 Jul; 29(7):1005-1009. PubMed ID: 28808734
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Poor Response and Adverse Events Following Botulinum Toxin-A for Refractory Idiopathic Overactive Bladder.
Abrar M; Stroman L; Malde S; Solomon E; Sahai A
Urology; 2020 Jan; 135():32-37. PubMed ID: 31626856
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.
Jiang YH; Liao CH; Tang DL; Kuo HC
PLoS One; 2014; 9(8):e105989. PubMed ID: 25148378
[TBL] [Abstract][Full Text] [Related]
25. Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
Miotla P; Cartwright R; Skorupska K; Bogusiewicz M; Markut-Miotla E; Futyma K; Rechberger T
Int Urogynecol J; 2017 Jun; 28(6):845-850. PubMed ID: 27889830
[TBL] [Abstract][Full Text] [Related]
26. Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder.
Gotoh D; Torimoto K; Takamatsu N; Onishi K; Morizawa Y; Hori S; Nakai Y; Miyake M; Fujimoto K
In Vivo; 2024; 38(3):1332-1337. PubMed ID: 38688605
[TBL] [Abstract][Full Text] [Related]
27. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
J Urol; 2013 Jun; 189(6):2186-93. PubMed ID: 23246476
[TBL] [Abstract][Full Text] [Related]
28. Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome.
Liu HT; Chen SH; Chancellor MB; Kuo HC
PLoS One; 2015; 10(8):e0134803. PubMed ID: 26241848
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity.
Liao CH; Kuo HC
J Urol; 2013 May; 189(5):1804-10. PubMed ID: 23178902
[TBL] [Abstract][Full Text] [Related]
31. Safety of Intradetrusor OnabotulinumtoxinA (BTX-A) Injection in the Asymptomatic Patient With a Positive Urine Dip.
Derisavifard S; Giusto LL; Zahner P; Rueb JJ; Goldman HB
Urology; 2020 Jan; 135():38-43. PubMed ID: 31600558
[TBL] [Abstract][Full Text] [Related]
32. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
35. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
Chen SF; Chang CH; Kuo HC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
[TBL] [Abstract][Full Text] [Related]
36. Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings.
Kennelly M; Green L; Alvandi N; Wehbe S; Smith JJ; MacDiarmid S; Mangel J; Schwartz M; Aboushwareb T; Murray B
Curr Med Res Opin; 2018 Oct; 34(10):1771-1776. PubMed ID: 29458265
[TBL] [Abstract][Full Text] [Related]
37. Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.
Kuo HC
Neurourol Urodyn; 2011 Nov; 30(8):1497-502. PubMed ID: 21717501
[TBL] [Abstract][Full Text] [Related]
38. Predictors for adverse events following intravesical botulinum toxin injections in men.
Ribeiro L; Leung LY; Tan N; Low ZY; Nagarajah M; Ahmed G; Carey M; Sabbagh S; Sharma D; Seth J
Neurourol Urodyn; 2023 Sep; 42(7):1499-1505. PubMed ID: 37386824
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
[TBL] [Abstract][Full Text] [Related]
40. Long-term compliance and results of intravesical botulinum toxin A injections in male patients.
Rahnama'i MS; Marcelissen TAT; Brierley B; Schurch B; de Vries P
Neurourol Urodyn; 2017 Sep; 36(7):1855-1859. PubMed ID: 28084637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
